Clinical Trials in North Carolina

Showing 10621-10640 of 20,428 trials

Safety Study of LLF580 in Obese Volunteers

NCT03466203

The purpose of the study is to evaluate the safety and tolerability of multiple doses of LLF580 administered subcutaneously over 3 months in obese subjects. In addition, the study will also determine early efficacy signals in various metabolic diseases associated with elevated triglycerides and/or obesity.

Obesity

Novartis Pharmaceuticals61 participantsStarted Feb 2018

Jacksonville, Florida, United States • Miami, Florida, United States • Overland Park, Kansas, United States +4 more locations

COMPLETEDPhase 341 miles

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

NCT04334148

This is a double blind, placebo controlled study in approximately 2,000 health care workers at risk for being exposed to COVID-19. Eligible participants will be randomly assigned (1:1) to either treatment group (HCQ) or placebo in a double-blind fashion. Course of treatment is 30 days.

COVID-19

Adrian Hernandez1,360 participantsStarted Apr 2020

Aurora, Colorado, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +31 more locations

Safety Study of LLF580 in Obese Volunteers

Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine

Find Trials by Condition in North Carolina

The (PIVOTAL) Study

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections

Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

Study of Efficacy and Safety of LOU064 in Inadequately Controlled Asthma Patients

Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHT

Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia

A Safety Extension Study to Evaluate the Long-term Safety of QGE031 in Chronic Spontaneous Urticaria (CSU) Patients

A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder

Knee Kinematics for Subjects With Zimmer-Biomet Posterior Cruciate Retaining or Posterior Stabilizing Total Knee Arthroplasty

A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients

A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC

Study of Efficacy and Safety of Secukinumab 2 mL Auto-injector (300 mg) in Subjects With Moderate to Severe Plaque Psoriasis

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)

Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma